Michael Pishvaian, MD, PhD

Associate Professor of Oncology
Johns Hopkins University, Washington, DC

Authored Articles

Deciding Between Triplet Therapy for the Treatment of Pancreatic Cancer: NALIRIFOX and FOLFIRINOX
Tanios S. Bekaii-Saab, MD, Shubham Pant, MD, Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Deciding Which Patients Are Best Suited for Various First-Line Pancreatic Cancer Treatment Options
Tanios S. Bekaii-Saab, MD, Shubham Pant, MD, Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Considerations for Selecting a First-Line Pancreatic Cancer Treatment
Tanios S. Bekaii-Saab, MD, Shubham Pant, MD, Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
How the Cost of Cancer Treatments May Affect Treatment Decisions for Patients
Tanios S. Bekaii-Saab, MD, Shubham Pant, MD, Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Best Practices for Treating Adverse Events Associated With Pancreatic Cancer Therapies
Tanios S. Bekaii-Saab, MD, Shubham Pant, MD, Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Key Side Effects That May Occur With First-Line Treatments for Patients With Pancreatic Cancer
Tanios S. Bekaii-Saab, MD, Shubham Pant, MD, Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
The Importance of Median Progression-Free Survival in Oncology Clinical Trials
Tanios S. Bekaii-Saab, MD, Shubham Pant, MD, Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Median Overall Survival of First-Line Treatments for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Tanios S. Bekaii-Saab, MD, Shubham Pant, MD, Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article
Evaluation of Patients for Pancreatic Cancer
Tanios S. Bekaii-Saab, MD, Shubham Pant, MD, Michael Pishvaian, MD, PhD
Interview with the Innovators
Videos
Read Article

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.

We Value Your Feedback! Tell Us How You Consume Content

Your feedback will help us tailor our content to better meet your needs and preferences.

*First Name
*Last Name
*Email
*What's your favorite format for experiencing our content?